Aziende Chimiche Riunite Angelini Francesco S.p.a
Clinical trials sponsored by Aziende Chimiche Riunite Angelini Francesco S.p.a, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cenobamate tested in real life for stubborn seizures Results expected Mar 2027 (estimated)
-
Lozenges put to the taste test: which flavor wins?
Knowledge-focused CompletedThis study involved 120 healthy volunteers (60 adults and 60 children) who tasted five different flavored lozenges for 10 seconds each. They then answered a questionnaire about taste, aftertaste, and texture using a simple smiley-face scale. The goal was to see which flavor peopl…
Phase 1 • Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New trazodone formula tested for similarity to current version
Knowledge-focused CompletedThis study tested whether a new polymer version of the antidepressant trazodone (150 mg and 300 mg tablets) is absorbed in the body the same way as the current Contramid® version. Sixty-four healthy adults took both forms in a crossover design to measure drug levels in the blood.…
Phase 1 • Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:07 UTC